✦ LIBER ✦

O-95 TOPO II is an independent predictor of survival in unselected breast cancer

✍ Scribed by A. Pancholi; D.G. Powe; R.M. Ganesh; M. Lambros; J.S. Reis-Filho; E. Rakha; I.O. Ellis

Book ID: 118626051
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 42 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(07)71785-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-93 ALCAM is an independent predictor o

O-93 ALCAM is an independent predictor of survival in unselected breast cancer

✍ R. Murali-Ganesh; D.G. Powe; A. Pancholi; G.R. Ball; E. Rakha; I.O. Ellis 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Neutrophil-Lymphocyte Ratio – An Indepen

Neutrophil-Lymphocyte Ratio – An Independent Predictor of Survival in Breast Cancer

✍ A. Hakeem; M. West; E. Stefanidis; R. Hardy; L. Martin 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Histochemical estrogen binding An indepe

Histochemical estrogen binding An independent predictor of recurrence and survival in stage II breast cancer

✍ Joseph G. Feldman; Louis P. Pertschuk; Anne C. Carter; Karen B. Eisenberg; Jay F 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Survivin is an independent predictor of

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients

✍ Hinnis, A R; Luckett, J C A; Walker, R A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Is Serum Albumin an Independent Predicto

Is Serum Albumin an Independent Predictor of Survival in Ovarian Cancer?

✍ Digant Gupta; Carolyn A. Lammersfeld; Pankaj G. Vashi; Sadie Dahlk; James F. Gru 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 96 KB

Hypertension is an independent predictor

Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients

✍ Dejana Braithwaite; C. Martin Tammemagi; Dan H. Moore; Elissa M. Ozanne; Robert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB

## Abstract The objective of this study was to determine whether comorbidity, or pre‐existing conditions, can account for some of the disparity in survival between African‐American and white breast cancer patients. A historical cohort study was conducted of 416 African‐American and 838 white women